LENZ · LENZ Therapeutics, Inc.
$4.73
+0.13 (+2.83%)
At close · Aug 14
Market Cap
$148.62M
Shares
31.42M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-04-04 | — | — | — | — | 8-K , filed 2025-10-08 |
Key facts
CIK
1815776
CUSIP
52635N103
13F (30d)
139 filings
138 filers
Visit website
Investor relations